| GO ID | GO Description | Gene(n) | p-Value |
| GO:0030900 | forebrain development | 11 | 5.58E-06 |
| GO:0007189 | activation of adenylate cyclase activity by G-protein signaling pathway | 9 | 1.45E-05 |
| GO:0007267 | cell-cell signaling | 22 | 8.41E-05 |
| GO:0008543 | fibroblast growth factor receptor signaling pathway | 7 | 0.0002 |
| GO:0016338 | calcium-independent cell-cell adhesion | 6 | 0.0003 |
| GO:0007204 | elevation of cytosolic calcium ion concentration | 11 | 0.0005 |
| GO:0008286 | insulin receptor signaling pathway | 7 | 0.0005 |
| GO:0010552 | positive regulation of gene-specific transcription from RNA polymerase II promoter | 9 | 0.0006 |
| GO:0021983 | pituitary gland development | 5 | 0.0007 |
| GO:0007588 | excretion | 7 | 0.0007 |
| GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 3 | 0.0007 |
| GO:0000080 | G1 phase of mitotic cell cycle | 4 | 0.0012 |
| GO:0045941 | positive regulation of transcription | 13 | 0.0014 |
| GO:0007190 | activation of adenylate cyclase activity | 5 | 0.0025 |
| GO:0032526 | response to retinoic acid | 6 | 0.0025 |
| GO:0007613 | memory | 5 | 0.0029 |
| GO:0030901 | midbrain development | 4 | 0.0032 |
| GO:0031100 | organ regeneration | 5 | 0.0033 |
| GO:0007187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 6 | 0.0036 |
| GO:0045776 | negative regulation of blood pressure | 4 | 0.0039 |
| GO:0006813 | potassium ion transport | 13 | 0.0040 |
| GO:0006928 | cellular component movement | 10 | 0.0042 |
| GO:0008285 | negative regulation of cell proliferation | 19 | 0.0046 |
| GO:0007218 | neuropeptide signaling pathway | 9 | 0.0047 |
| GO:0045995 | regulation of embryonic development | 3 | 0.0050 |
| GO:0060173 | limb development | 3 | 0.0050 |
| GO:0007193 | inhibition of adenylate cyclase activity by G-protein signaling pathway | 5 | 0.0050 |
| GO:0014070 | response to organic cyclic substance | 8 | 0.0059 |
| GO:0001558 | regulation of cell growth | 7 | 0.0063 |
| GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure | 2 | 0.0064 |
| GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure | 2 | 0.0064 |
| GO:0010871 | negative regulation of receptor biosynthetic process | 2 | 0.0064 |
| GO:0031649 | heat generation | 2 | 0.0064 |
| GO:0090083 | regulation of inclusion body assembly | 2 | 0.0064 |
| GO:0032582 | negative regulation of gene-specific transcription | 4 | 0.0065 |
| GO:0032496 | response to lipopolysaccharide | 8 | 0.0074 |
| GO:0042593 | glucose homeostasis | 6 | 0.0074 |
| GO:0043627 | response to estrogen stimulus | 6 | 0.0074 |
| GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 19 | 0.0085 |
| GO:0042755 | eating behavior | 4 | 0.0088 |
| GO:0050873 | brown fat cell differentiation | 4 | 0.0088 |
| GO:0008283 | cell proliferation | 19 | 0.0093 |